The U.S. Supreme Court has prevented 592 nonresidents from joining 86 California residents in suing Bristol-Myers Squibb in California state court for personal injury allegedly caused by Plavix, a blood thinner. At the state level, the California Supreme Court concluded that the Due Process Clause of the 14th Amendment did not bar the out-of-state residents from suing the corporation, BMS, in state court.
In the vigorous dissent written by Justice Sonia M. Sotomayor, the U.S. Supreme Court reversed. Justice Samuel A. Alito Jr.’s majority opinion explained, “The nonresidents were not prescribed Plavix in California, did not purchase Plavix in California, did not ingest Plavix in California and were not injured by Plavix in California.
The mere fact that other plaintiffs were prescribed, obtained and ingested Plavix in California – and allegedly sustained the same injuries as did the nonresidents – does not allow the state to assert specific jurisdiction over the nonresidents’ claims.”
Continue reading